Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Levice

155 clinical trials in Levice, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Levice at a glance
155
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

155 trials in Levice

Open in trial search

Crohn's disease

Recruiting

Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International

Cardiac failure

Recruiting

Study of maridebart cafraglutide for patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Lunsekimig
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:LY4268989 adipic acid
  • Sponsor:Eli Lilly & Co.

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Zilebesiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Colorectal cancer+1

Recruiting

Study of NGM120 in patients with colorectal cancer and cancer cachexia: Evaluating effects on body weight

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:NGM120
  • Sponsor:Ngm Biopharmaceuticals Inc.

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB

Crohn's disease

Recruiting

Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC

Cardiac failure

Recruiting

Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Colitis ulcerative+1

Recruiting

Study on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn's Disease

InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.

Crohn's disease

Recruiting

Study on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Crohn's Disease

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:RO7790121
  • Sponsor:F. Hoffmann-La Roche AG

Other cities in Slovakia

The busiest research cities in the country

All 88 cities in Slovakia

Clinical research in Levice

What the registry says about research in the country

01 Cardiovascular Diseases

In Levice, cardiovascular disease research focuses on preventing serious events such as stroke, heart attack, and other vascular complications. These studies are designed to assess new options for stroke prevention, atherosclerotic cardiovascular disease, and related risk reduction.

  • Acute ischemic stroke and high-risk transient ischemic attack
  • Atrial fibrillation with prevention of stroke or systemic embolism
  • Atherosclerotic cardiovascular disease and systemic inflammation
  • High LDL cholesterol and broader cardiovascular risk

The trials are mainly evaluating whether new treatments can improve protection against major cardiovascular events and support better long-term outcomes.

02 Respiratory Tract Diseases

A large share of the clinical research in Levice is centered on asthma and chronic obstructive pulmonary disease. These studies explore ways to improve breathing control, reduce flare-ups, and slow the decline in lung function in people with persistent respiratory symptoms.

  • Moderate to severe asthma and uncontrolled asthma
  • Chronic obstructive pulmonary disease and chronic bronchitis
  • Asthma with frequent exacerbations
  • Severe COPD outcomes and lung function decline

Overall, the research is aimed at testing new therapies and combination treatments that may help people breathe more easily and stay stable for longer.

03 Nutritional and Metabolic Diseases

Clinical trials in this area examine overweight, obesity, type 2 diabetes, and hyperlipidemia. The goal is to better understand treatment approaches that may support weight reduction and improve metabolic health.

  • Overweight or obesity with type 2 diabetes
  • Hyperlipidemia and elevated cardiovascular risk
  • Weight management in people with metabolic disease
  • Metabolic risk linked to heart and vascular complications

These studies are mainly testing whether newer therapies can improve key health markers and reduce the burden of metabolic disease.

04 Skin and Connective Tissue Diseases

Research in skin and connective tissue diseases is represented by studies on chronic spontaneous urticaria. The main purpose is to evaluate treatments that may improve symptom control and provide longer-lasting relief for people with persistent allergic skin disease.

  • Chronic spontaneous urticaria
  • Long-term symptom control
  • Relapse prevention and treatment durability

This area adds a focused immunology component to the clinical trial landscape in Levice.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.